RT @POCOG1: Our #ConquerFear mediators/moderators paper published. Exploring who benefits most from #CF when they have #FearOfCancerRecurre…
RT @cancer_K2A: 8/10 Many of these #cancer #fearofrecurrence models need 2 b tested, but there's ⬆️evidence for the role of #metacognitions…
RT @cancer_K2A: 8/10 Many of these #cancer #fearofrecurrence models need 2 b tested, but there's ⬆️evidence for the role of #metacognitions…
RT @cancer_K2A: 8/10 Many of these #cancer #fearofrecurrence models need 2 b tested, but there's ⬆️evidence for the role of #metacognitions…
8/10 Many of these #cancer #fearofrecurrence models need 2 b tested, but there's ⬆️evidence for the role of #metacognitions in #FCR in Australian https://t.co/n2R3B5cgHL & Chinese #cancersurvivors https://t.co/Ng1v1vtUCb & how ⬇️ metacognitions ca
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
RT @POCOG1: Our #ConquerFear mediators/moderators paper published. Exploring who benefits most from #CF when they have #FearOfCancerRecurre…
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
RT @POCOG1: This #Tweetorial by @LSharpeUSYD summarises the findings of the #ConquerFear mediators/moderators analysis - fascinating inform…
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
This #Tweetorial by @LSharpeUSYD summarises the findings of the #ConquerFear mediators/moderators analysis - fascinating information. #FCR #FearOfCancerRecurrence #PsyOnc
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
RT @amadorpriede: Resultados del análisis de mediadores y moderadores de la intervención #ConquerFear para miedo a recaídas en supervivient…
Resultados del análisis de mediadores y moderadores de la intervención #ConquerFear para miedo a recaídas en supervivientes de cáncer. Aquellos con más miedo a recaídas se benefician más de la intervención. @POCOG1 https://t.co/RLwMuuPz22
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
RT @POCOG1: Our #ConquerFear mediators/moderators paper published. Exploring who benefits most from #CF when they have #FearOfCancerRecurre…
Our #ConquerFear mediators/moderators paper published. Exploring who benefits most from #CF when they have #FearOfCancerRecurrence #FCR? #How does CF work? Great work from a great team. https://t.co/oIRnrmqS7c #PsyOnc #SuppOnc
RT @GrierMaree: Getting under the hood and seeing how the ConquerFear engine runs! Super helpful for clinical practice. https://t.co/ulOhT1…
Getting under the hood and seeing how the ConquerFear engine runs! Super helpful for clinical practice.
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
RT @cancer_K2A: Now that the efficacy of several interventions for #cancer #FearOfRecurrence, such as #ConquerFear, has been demonstrated i…
RT @hagsie: Read this new paper from @pocog1 members about mechanisms in #FCR & read author @LSharpeUSYD’s #tweetorial interpreting the res…
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
RT @LSharpeUSYD: NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF?…
RT @cancer_K2A: Now that the efficacy of several interventions for #cancer #FearOfRecurrence, such as #ConquerFear, has been demonstrated i…
RT @cancer_K2A: Now that the efficacy of several interventions for #cancer #FearOfRecurrence, such as #ConquerFear, has been demonstrated i…
RT @cancer_K2A: Now that the efficacy of several interventions for #cancer #FearOfRecurrence, such as #ConquerFear, has been demonstrated i…
Read this new paper from @pocog1 members about mechanisms in #FCR & read author @LSharpeUSYD’s #tweetorial interpreting the results. Great work #Aussie #PsyOnc people @UsydPsych @CancerAustralia @COSA_Surviv @SydCancerNetwrk
RT @cancer_K2A: Now that the efficacy of several interventions for #cancer #FearOfRecurrence, such as #ConquerFear, has been demonstrated i…
Now that the efficacy of several interventions for #cancer #FearOfRecurrence, such as #ConquerFear, has been demonstrated it's great to see further investigations being done to understand how they work and who they work best for. Great work by @LSharpeUSYD
NEW PAPER ALERT!! Really pleased to see the #CONQUERFEAR mediators/moderators paper published. Who benefits most from CF? How does CF work? @POCOG1 @cancer_K2A @Afaf_Girgis @FORWARDS_SIG @UsydPsych @CPU_USYD https://t.co/Tu1R8iT7GE